Previous 10 | Next 10 |
Pyxis Tankers PXS -22% on Q3 earnings release.Casper Sleep CSPR -13% on Q3 earnings release.Hall of Fame Resort & Entertainment (HOFV) -12%.Nautilus (NLS) -10%.EuroDry (EDRY) -9%.Sino-Global Shipping America (SINO) -9%.Co-Diagnostics (CODX) -16%.BioNTech BNTX -8%&...
FinancialBuzz.com News Commentary New York, NY (11/13/2020) – The pandemic is in full swing once again; the daily U.S. death toll crossed the 2,000 mark on Wednesday as weeks of rising infection rates are now manifesting in mortality numbers not seen since May. In addition, the m...
Co-Diagnostics' (CODX) jumps 9% premarket after its recent report demonstrates that the CoPrimer platform technology can be used to identify the presence of SARS-CoV-2 in human saliva without first requiring RNA extraction of the sample, while providing low limits of detection. The ...
Co-Diagnostics, Inc. CoPrimers™ Shown to be Effective in COVID-19 Saliva PCR Tests Without Sample Extraction PR Newswire SALT LAKE CITY, Nov. 11, 2020 SALT LAKE CITY , Nov. 11, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular d...
Co-Diagnostics, Inc. Announces Q3 2020 Earnings Release Date and Earnings Webcast PR Newswire SALT LAKE CITY, Nov. 10, 2020 SALT LAKE CITY , Nov. 10, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, ...
Clinical Reference Laboratory to Market Most Cost-Effective, Gold-Standard Self-Collected COVID-19 Saliva Test Directly to Consumers Highly Accurate CRL Rapid Response™ Saliva Test is Easy to Use, Competitively Priced; Delivers Results Right to Cell Phone PR Newswire ...
Palm Beach, FL – November 5, 2020 – Covid-19 tests are critical in the management of the ongoing COVID-19 pandemic for accurate diagnosis as well as for tackling the spread of the infection. Over 600 SARS-CoV-2 diagnostic tests are either approved or are in the development pha...
Co-Diagnostics, Inc. to Amend Q2 2020 Form 10-Q to Show $0.51 Net Income per Share PR Newswire SALT LAKE CITY, Utah, Nov. 2, 2020 SALT LAKE CITY, Utah , Nov. 2, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a u...
Gainers: Document Security Systems (DSS) +43%.Muscle Maker (GRIL) +39%.Lianluo Smart (LLIT) +35%.Co-Diagnostics (CODX) +19%.SilverSun Technologies (SSNT) +18%.Mid-Con Energy Partners (MCEP) +18%.Galera Therapeutics (GRTX) +15%.Dunkin' Brands (DNKN) +15%.GeoVax Labs (GOVX) +14%.Selec...
Co-Diagnostics (NASDAQ: CODX) is up a ridiculous 1,240% this year, but the stock has dropped more than 45% in the past three months. It's probably right to wonder if its run is over, and whether it's still a good time to buy the molecular-diagnostics company, which marketed highly a...
News, Short Squeeze, Breakout and More Instantly...
Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC Diagnostics at ADLM 2024 in Chicago PR Newswire SALT LAKE CITY , July 29, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company wi...
Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY , July 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the developme...
Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States PR Newswire SALT LAKE CITY , July 2, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx™"), a molecular diagnostics company w...